Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells

Disease relapse remains a major factor limiting the survival of cancer patients. In the plasma cell malignancy multiple myeloma (MM), nearly all patients ultimately succumb to disease relapse and progression despite new therapies that have improved remission rates. Tumor regrowth indicates that clon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tanno, Toshihiko, Lim, Yiting, Wang, Qiuju, Chesi, Marta, Bergsagel, P. Leif, Matthews, Geoff, Johnstone, Ricky W., Ghosh, Nilanjan, Borrello, Ivan, Huff, Carol Ann, Matsui, William
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2014
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3907757/
https://ncbi.nlm.nih.gov/pubmed/24345755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-08-524025
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars